ARTICLE | Company News
Management tracks
February 21, 2015 1:42 AM UTC
Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) promoted Lisa Bright to chief commercial and corporate affairs officer. Bright joined Intercept last year as SVP and head of Europe. She previously held several positions at Gilead Sciences Inc. (NASDAQ:GILD), including VP, head of Sovaldi launch planning for Europe, Asia, Middle East and Australasia.
Nuclea Biotechnologies Inc. (Pittsfield, Mass.) hired Mary Lopez as COO. Lopez was director of the BRIMS Center at Thermo Fisher Scientific Inc. (NYSE:TMO). ...